Details for New Drug Application (NDA): 020815

✉ Email this page to a colleague

NDA 020815 describes EVISTA, which is a drug marketed by Lilly and is included in one NDA. It is available from one supplier. Additional details are available on the EVISTA profile page.

The generic ingredient in EVISTA is raloxifene hydrochloride. There are seventeen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the raloxifene hydrochloride profile page.

Summary for 020815

Tradename:	EVISTA
Applicant:	Lilly
Ingredient:	raloxifene hydrochloride
Patents:	0

Pharmacology for NDA: 020815

Mechanism of Action	Selective Estrogen Receptor Modulators

Medical Subject Heading (MeSH) Categories for 020815

Bone Density Conservation Agents
Estrogen Antagonists
Selective Estrogen Receptor Modulators

Suppliers and Packaging for NDA: 020815

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
EVISTA	raloxifene hydrochloride	TABLET;ORAL	020815	NDA	Eli Lilly and Company	0002-4184	0002-4184-30	30 TABLET in 1 BOTTLE (0002-4184-30)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	60MG
Approval Date:	Dec 9, 1997	TE:	AB	RLD:	Yes

Expired US Patents for NDA 020815

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Lilly	EVISTA	raloxifene hydrochloride	TABLET;ORAL	020815-001	Dec 9, 1997	⤷ Subscribe	⤷ Subscribe
Lilly	EVISTA	raloxifene hydrochloride	TABLET;ORAL	020815-001	Dec 9, 1997	⤷ Subscribe	⤷ Subscribe
Lilly	EVISTA	raloxifene hydrochloride	TABLET;ORAL	020815-001	Dec 9, 1997	⤷ Subscribe	⤷ Subscribe
Lilly	EVISTA	raloxifene hydrochloride	TABLET;ORAL	020815-001	Dec 9, 1997	⤷ Subscribe	⤷ Subscribe
Lilly	EVISTA	raloxifene hydrochloride	TABLET;ORAL	020815-001	Dec 9, 1997	⤷ Subscribe	⤷ Subscribe
Lilly	EVISTA	raloxifene hydrochloride	TABLET;ORAL	020815-001	Dec 9, 1997	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.